NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition by New Mountain Capital for $13.25 per share. If you invested in R1 RCM, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/r1-rcm-inc. Why is R1 RCM being Investigated by BFA Law? R1 RCM is controlled by funds affiliated with New Mountain Capital and TowerBrook through their collective ownership of Company stoc ...

MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice President and Chief Technology Officer. S ...

MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webcast will be ...

R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Evan Smith - Senior Vice President, Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Elizabeth Anderson - Evercore Jailendra Singh - Truist Securities Sean Dodge - RBC Capital Markets George Hill - Deutsche Bank Jack Wallace - Guggenheim Securities Michael Cherny - Leerin ...

First Quarter 2024 Earnings Call Nasdaq: RCM May 8, 2024 Forward-Looking Statements This pre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-41428 R1 RCM INC. (Exact name of registrant as specified in its charter) Delaware 87-4340782 (State or other jurisdiction of (I ...

Exhibit 99.1 R1 RCM Reports First Quarter 2024 Results Murray, Utah - May 8, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: • Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same peri ...

R1 RCM Inc. (NASDAQ:RCM) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET Company Participants Evan Smith - Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jailendra Singh - Truist Securities Stephanie Davis - Barclays Charles Rhyee - TD Cowen Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Elizabeth Anderson - Evercore Partner Vikram Kesavabhotla - Baird Allen Lutz - Bank ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41428 R1 RCM Inc. (Exact name of registrant as specified in its charter) Delaware 87-4340782 (State or other jurisdiction of incorpor ...

Fourth Quarter & Full Year 2023 Earnings Call Nasdaq: RCM • February 27, 2024 11 Forward- ...